LA VILLA, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 7.457
EU - Europa 4.411
AS - Asia 2.676
SA - Sud America 310
AF - Africa 79
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 12
Totale 15.005
Nazione #
US - Stati Uniti d'America 7.355
RU - Federazione Russa 1.518
IT - Italia 789
SG - Singapore 742
HK - Hong Kong 527
CN - Cina 515
SE - Svezia 475
IE - Irlanda 405
VN - Vietnam 282
PL - Polonia 279
KR - Corea 276
UA - Ucraina 261
BR - Brasile 254
DE - Germania 221
FI - Finlandia 139
FR - Francia 129
IN - India 101
GB - Regno Unito 90
AU - Australia 60
JP - Giappone 57
CA - Canada 56
CH - Svizzera 49
TR - Turchia 44
BD - Bangladesh 33
JO - Giordania 27
AR - Argentina 23
CI - Costa d'Avorio 21
NG - Nigeria 18
NL - Olanda 18
MX - Messico 16
IQ - Iraq 15
CO - Colombia 12
ZA - Sudafrica 10
PK - Pakistan 9
VE - Venezuela 8
BE - Belgio 7
EC - Ecuador 7
EG - Egitto 7
HN - Honduras 7
SC - Seychelles 7
ES - Italia 6
ID - Indonesia 6
JM - Giamaica 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
MA - Marocco 5
UZ - Uzbekistan 5
CL - Cile 4
CR - Costa Rica 4
PH - Filippine 4
PT - Portogallo 4
SA - Arabia Saudita 4
BY - Bielorussia 3
CZ - Repubblica Ceca 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AL - Albania 2
GT - Guatemala 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
GP - Guadalupe 1
GR - Grecia 1
IL - Israele 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
TN - Tunisia 1
UG - Uganda 1
Totale 14.994
Città #
Santa Clara 1.516
Fairfield 624
Ashburn 604
Singapore 507
Chandler 427
Hong Kong 427
Jacksonville 415
Dublin 404
San Jose 329
Woodbridge 322
Cambridge 283
Warsaw 277
Seattle 273
Seoul 271
Houston 238
Wilmington 238
Milan 200
Beijing 183
Los Angeles 133
Buffalo 120
The Dalles 120
Princeton 103
Ann Arbor 93
Ho Chi Minh City 90
Hanoi 84
Lauterbourg 83
Boardman 82
Boston 79
Dallas 69
Rome 66
Melbourne 60
Lawrence 56
Mumbai 56
Tokyo 56
Bern 49
Hefei 49
Altamura 47
Medford 43
San Diego 41
Munich 37
Moscow 35
New York 33
Florence 28
Izmir 28
Naples 25
Paris 24
Turku 23
Shanghai 22
Abidjan 21
Kent 20
Norwalk 20
São Paulo 20
Abuja 18
Palermo 18
Turin 17
Verona 15
Bologna 14
Council Bluffs 14
Helsinki 14
London 14
Auburn Hills 13
Falls Church 13
Redondo Beach 13
Bremen 12
Toronto 12
Da Nang 11
Dearborn 11
Frankfurt am Main 11
Frankfurt Am Main 10
Haiphong 10
Orem 10
Baghdad 9
Biên Hòa 9
Chennai 9
Genoa 9
Andover 8
Atlanta 8
Montreal 8
Salerno 8
Tianjin 8
Yubileyny 8
Brooklyn 7
Chicago 7
Guangzhou 7
Rio de Janeiro 7
Venice 7
Washington 7
Amman 6
Bari 6
Belo Horizonte 6
Brescia 6
Brussels 6
Curitiba 6
Hillsboro 6
Manchester 6
Miano 6
San Francisco 6
Stockholm 6
Amsterdam 5
Bergamo 5
Totale 9.905
Nome #
THAD in biliary duct disease 349
Spiral computed tomography versus ultrasound in the follow up of cirrhotic patients previously treated for hepatocellular carcinoma: a prospective study 316
The kinin system and other vasoactive substances in chronic liver disease. 242
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 221
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 220
"Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease 216
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 205
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 205
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 202
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 200
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 195
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 194
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 192
Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. 191
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 190
Analysis of HCV persistence in patients with sustained virological response 190
Ascites and hepatorenal syndrome 187
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 187
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 185
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 185
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 185
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 185
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 181
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 181
High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. 181
Functional renal alterations in chronic liver diseases. 180
Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. 179
Loop diuretic therapy in liver cirrhosis with ascites 174
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 170
Liver-kidney pathophysiological interrelationships in liver diseases. 169
Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. 167
T(14;18) translocation in chronic hepatitis C virus infection 166
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 165
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 163
Torasemide in the treatment of patients with cirrhosis and ascites. 158
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 158
Pathogenesis and treatment of ascites in hepatic cirrhosis. 157
CARDIOVASCULAR EFFECTS OF PARATHYROID HORMONE: A STUDY IN HEALTHY SUBJECTS AND NORMOTENSIVE PATIENTS WITH MILD PRIMARY HYPERPARATHYROIDISM 157
Hepato-systemic gradient of carbon monoxide in cirrhosis. 156
In vivo evidence that endogenous dopamine modulates sympathetic activity in man. 153
Transient Hepatic Attenuation Differences - Pictorial Essay 150
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 150
Purification of PGE2 in the urine of cirrhotic patients: comparison of three chromatographic techniques. 149
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 149
Behaviour of sustained responders to anti-HCV treatment: may HCV infection be eradicated? 149
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 148
Hemodynamic alterations in liver cirrhosis. 147
High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure 146
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 146
[Determination of prostaglandin E2 and F2 alpha in the urine of cirrhotic patients: comparison of 3 different chromatographic methods] 146
Uveitis in autoimmune hepatitis: a case report. 145
[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications] 144
Pathogenesis and treatment of ascites in hepatic cirrhosis. 141
Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure. 139
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. 135
Comportamento dell'infezione da HCV in pazienti trapiantati per HCC complicante una cirrosi HCV-correlata 135
Urinary endothelin-1 excretion is enhanced by low-dose infusion of brain natriuretic peptide in normal humans. 135
Il Fegato: Fisiopatologia, Clinica, Terapia 134
Pathogenesis and management of the hepatorenal syndrome. 132
Vascular reserve in the lower limbs of cirrhotic patients: a duplex Doppler ultrasound study. 131
Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites 130
Multiple immune disorders in unrecognized celiac disease: a case report 130
Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis. 130
Renal effects of atrial natriuretic peptide during dopa-decarboxylase inhibition in patients with essential hypertension. 130
Renal impairement in chronic liver diseases with and without cholestasis 129
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour 128
Impaired cardiovascular autonomic response to passive tilting in cirrhosis with ascites. 128
Hepatorenal syndrome and its treatment today. 127
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. 126
Arachidonic acid derivatives and renal function in liver cirrhosis. 125
Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. 125
Hemodynamic, renal and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 123
Effects of clonidine on power spectral analysis of heart rate variability in mild essential hypertension. 122
Cerebral autoregulation in patients with cirrhosis and ascites. A transcranial Doppler study. 121
Systemic haemodynamics, renal and platelet function during chronic propranolol ADMINISTRATION IN PATIENTS WITH COMPENSATED CIRRHOSIS 121
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. 121
Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension. 118
Dopamine and sympathoadrenal activity in man. 117
Long course and prognostic factors of virus-induced cirrhosis of the liver. 115
Hepatitis C virus infction of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. 111
Effects of acute clonidine administration on power spectral analysis of heart rate variability in healthy humans. 106
Effects of OKY 046, a thromboxane-sinthase inhibitor, on renal function in non-azotemic cirrhotic patients with ascites 106
Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion. 106
Refractory ascites: definition, pathogenesis and treatment. 105
Presence of BCL-2 rearranged B-cell clones in chronic HCV infection may negatively influence virological response to treatment 105
Persistence of HCV in hepatic and extrahepatic cells from asymptomatic non viremic chronic anti-HCV carriers. 101
Vasoactive factors in decompensated cirrhosis. Effect of acute plasma expansion. 99
Low-dose C-natriuretic peptide does not affect cardiac and renal function in man 99
La Cirrosi Epatica Virus-correlata: Storia Naturale, patogenesi e implicazioni cliniche dellew complicanze. 95
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 94
Virological analysis of the healthy HCV carrier state: prognostic factors and HCV persistence in non viraemic subjects 94
Prevalenza della ricombinazione Bcl-2 in pazienti con crioglobulinemia mista HCV correlata complicata o meno da linfoma.. 91
Renal Impairment In Chronic Liver-Diseases With And Without Cholestasis. 91
Hemodynamic derangement and cardiac dysfunction in cirrhosis. 90
Prevalence of bcl-2 recombination in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma. 89
Prevalence of bcl-2 recombination in hepatitis C virus related mixed cryoglobulinemia with or without complicating B-cell lymphoma 87
Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis. 86
Il fegato: fisiopatologia, clinica, terapia 86
Prevalence of bcl-2 rearrangement in hepatitis C virus-related mixed cryoglobulinemia with or without complicating B-cell lymphoma 84
pathogenetic factors of renal dysfuntion in chronic liver disease 79
Totale 14.878
Categoria #
all - tutte 39.816
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.816


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022625 0 77 20 21 20 32 21 35 31 23 162 183
2022/20231.746 163 191 93 126 177 321 241 113 186 14 58 63
2023/2024495 25 76 102 28 36 69 14 112 6 4 12 11
2024/20254.154 125 431 288 636 1.453 389 30 247 231 89 119 116
2025/20264.107 555 548 251 326 430 126 445 186 362 202 75 601
2026/2027115 112 3 0 0 0 0 0 0 0 0 0 0
Totale 15.005